Skip to main content

Table 1 Baseline clinical and epidemiological characteristics of HIV infected patients

From: Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy

Characteristics

All patients

HIV groups

Low CD4+ recovery

High CD4+ recovery

p-value

No.

324

162

162

 

Male

264 (81.5%)

138 (85.2%)

126 (77.8%)

0.086

Age (years)

41.0 (34.7; 49.2)

43 (36.4; 51.3)

39.9 (33.8; 46.5)

0.001

Time since HIV diagnosis (years)

1 (1.0; 1.0)

1 (1.0; 2.0)

1 (1.0; 1.0)

0.117

CD4+ cell count at baseline (cells/μL)

105 (41; 159)

93.3 (37.5;147)

114.5 (41.5;165)

0.230

Hepatitis C infection

29 (8.9%)

16 (9.9%)

13 (8.0%)

0.559

Hepatitis B infection

14 (4.3%)

8 (4.9%)

6 (3.7%)

0.585

cART regimen

 PI-based

103 (31.8%)

45 (28.0%)

58 (35.8%)

0.469

 NNRTI-based

165 (51.1%)

88 (54.7%)

77 (47.5%)

 

 PI+ NNRTI-based

38 (11.8%)

20 (12.4%)

18 (11.1%)

 

 Others

17 (5.3%)

8 (5.0%)

9 (5.6%)

 

HIV transmission route

 IDU

51 (17.1%)

30 (20.8%)

21 (13.4%)

0.219

 Homosexual transmission

152 (50.8%)

68 (47.2%)

84 (54.2%)

 

 Heterosexual transmission

96 (32.1%)

46 (31.9%)

50 (32.3%)

 
  1. IDU intravenous drug users, HIV human immunodeficiency virus, cART combination antiretroviral therapy, PI HIV protease inhibitor, NNRTI non-nucleoside analogue HIV reverse transcriptase inhibitor
  2. Statistical: Values were expressed as absolute number (percentage) and median (percentile 25; percentile 75). Significant differences are shown in bold. p-values were calculated by Chi square and Mann–Whitney tests